MICHAEL D. LOBERG - 30 Jun 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Director
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
30 Jun 2023
Transactions value $
$0
Form type
4
Filing time
05 Jul 2023, 21:13:16 UTC
Previous filing
06 Apr 2023
Next filing
03 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $0 +1.14K $0.00 1.14K 30 Jun 2023 Direct F1, F2
holding IGMS Common Stock 46.8K 30 Jun 2023 See footnote F3
holding IGMS Common Stock 33.8K 30 Jun 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
F2 The number of shares held reflects the transfer on April 17, 2023 of 1,138 shares from the Reporting Person to Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees) (the "Revocable Deed of Trust").
F3 The shares are held by the Revocable Deed of Trust. The number of shares held reflects (i) the transfer on April 6, 2023 of 9,336 shares from Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees) ("Trust IX") to the Revocable Deed of Trust and (ii) the transfer on April 17, 2023 of 1,138 shares from the Reporting Person to the Revocable Deed of Trust.
F4 The shares are held by Trust IX. The number of shares held reflects the transfer on April 6, 2023 of 9,336 shares from Trust IX to the Revocable Deed of Trust.